| 1 |
34473771 | Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells. | 2021 |
4 |
| 2 |
29863120 | Glycogen synthase kinase-3β activity plays a key role in the antitumor effect of nafamostat mesilate in pancreatic cancer cells. | 2018 Jan |
2 |
| 3 |
30336548 | Nafamostat Mesilate Enhances the Radiosensitivity and Reduces the Radiation-Induced Invasive Ability of Colorectal Cancer Cells. | 2018 Oct 17 |
4 |
| 4 |
26546875 | Dual inhibition of nuclear factor kappa-B and Mdm2 enhance the antitumor effect of radiation therapy for pancreatic cancer. | 2016 Jan 28 |
1 |
| 5 |
27322737 | Inhibition of the NF-κB pathway by nafamostat mesilate suppresses colorectal cancer growth and metastasis. | 2016 Sep 28 |
3 |
| 6 |
22806547 | Inhibition of nuclear factor-κB enhances the antitumor effect of paclitaxel against gastric cancer with peritoneal dissemination in mice. | 2013 Jan |
2 |
| 7 |
23219147 | Inhibition of nuclear factor kappa-B enhances the antitumor effect of combination treatment with tumor necrosis factor-alpha gene therapy and gemcitabine for pancreatic cancer in mice. | 2013 Feb |
1 |
| 8 |
21484229 | Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition. | 2011 Sep |
3 |